April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Pars Plana Vitrectomy for Vitreoretinal Complications of Pars Planitis
Author Affiliations & Notes
  • L. Pelegrin
    Ophthalmology, Hospital Clinic, Barcelona, Spain
  • A. Adan Civera
    Ophthalmology, Hospital Clinic, Barcelona, Spain
  • M. Mesquida
    Ophthalmology, Hospital Clinic, Barcelona, Spain
  • N. Molina
    Ophthalmology, Hospital Clinic, Barcelona, Spain
  • Footnotes
    Commercial Relationships  L. Pelegrin, None; A. Adan Civera, None; M. Mesquida, None; N. Molina, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5883. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Pelegrin, A. Adan Civera, M. Mesquida, N. Molina; Pars Plana Vitrectomy for Vitreoretinal Complications of Pars Planitis. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5883.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Pars planitis is associated with vitreoretinal complications that can potentially cause severe visual loss. The aim of this study is to evaluate the effect of pars plana vitrectomy (PPV) in the management of patients with pars planitis.

Methods: : This retrospective study included patients who had undergone vitreoretinal surgery for vitreoretinal complications secondary to pars planitis. Visual acuity was compared between the last preoperative visit and the most recent follow-up visit. Intraoperative and postoperative complications were also analyzed

Results: : 22 eyes of 19 patients were included in the study, 12 men and 7 women. The mean age at surgery was 15.3 (± 8.8) years (SD 5 - 35 years). The mean follow-up was 55.7 (±39.6) months (SD 7 - 144 months). Indications for surgery were: persistents vitreous opacities in 10 eyes (45,4%) , vitreous hemorrhage in 9 eyes (40,9%) , and epiretinal membrane in 3 eyes (13,6%). Seven eyes had a visual acuity (VA) of 20/200 or less and 9 eyes between 20/200 and 20/60 preoperatively. Postoperatively, 18 eyes improved to a final VA of 20/40 or better, in 3 eyes the final VA was between 20/200 and 20/60, and none had a final VA of less 20/200. In 19 eyes there was improvement in the course of uveitis, allowing the discontinuation of immunosuppressive treatment.

Conclusions: : the results of this study suggest that pars plana vitrectomy have a beneficial effect on the course and visual function of patients with pars planitis, as well as reducing long-term immunosupression treatments.

Keywords: inflammation • uvea • clinical (human) or epidemiologic studies: outcomes/complications 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.